Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novartis to Acquire Avidity Biosciences in $12B Deal

Digest more
 · 2d · on MSN
Novartis’ Avidity Deal Is a Green Light for Biotech Rally
Novartis agreed to buy biotech firm Avidity Biosciences in a deal that values Avidity at around $12 billion, it announced on Sunday.The Swiss drugmaker is paying $72 a share cash for the San Diego-based biotech,

Continue reading

 · 2d
Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal
 · 2d · on MSN
Novartis to acquire Avidity Biosciences for about $12 billion
NJBIZ
2d

Novartis’ $12B Avidity acquisition to expand neuroscience pipeline

Novartis plans to acquire Avidity Biosciences to add RNA therapeutics to its neuroscience biz to target rare genetic ...
BioSpace
1d

Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem

Vas Narasimhan confirmed that Novartis is having weekly discussions with the Trump administration on drug pricing, but a deal ...
BioPharma Dive
3d

Novartis to acquire Avidity in $12B bet on RNA drugs for neuromuscular disease

The deal, which Novartis expects can “unlock multibillion-dollar opportunities” in the years ahead, hands the company a group ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms